Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Miaoshou Doctor Closes $85 Million Funding for Online-Offline Health Services

publication date: Jun 16, 2020

Miaoshou Doctor, an online-offline healthcare company headquartered in Beijing, closed an $85 million Series D1 round. The company offers online links between doctors and patients, online healthcare consultations and O2O services plus it operates a chain of over 200 offline pharmacies. Founded in 2015, the company says its focus is on "healthcare-medication-insurance." The company has raised at least $70 million in each of several C rounds and attained the unicorn $1 billion valuation. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital